Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RALOXIFEN ARENA 60 mg
Selective oestrogen receptor modulator, indicated in the prevention and treatment of postmenopausal osteoporosis
Active Substance (INN)
RALOXIFENUM HYDROCHLORIDUM
Packaging
1,2,6 blisters x 10 FCT
Adverse Reaction Reporting
To report an adverse reaction, please contact us using the email address below and provide all relevant information.
informatii.medicale@arenagroup.ro
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.